Identifying barriers to hypertension care: implications for quality improvement initiatives

Disease Management : DM
Nan HollandSteve Arcona

Abstract

The role of clinical inertia in the treatment of patients with hypertension was assessed by evaluating health care providers' knowledge, attitudes, and clinical practices regarding hypertension management. A cross-sectional survey was conducted at the Forsyth Medical Group in North Carolina. Participants were physicians (N = 18, 10 sites) and support staff (N = 20, 12 sites), who were surveyed in 2006. Physician and support staff questionnaires consisted of 29 and 15 items, respectively, and were administered by trained interviewers. Though most physicians (94%) cited familiarity with the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) guidelines and affirmed that hypertension management guidelines are relevant to their patients, no physicians interviewed routinely document patient hypertension management plans. Although 1 in 3 physicians cited the inability to devote enough time to patients for the discussion of hypertension management, physicians predominantly cited patient- and support-staff- related factors as most important to patients not attaining blood pressure (BP) goal. Patient lifestyle modification (89%), education (67%), and medicatio...Continue Reading

References

Feb 28, 2002·Archives of Internal Medicine·Susan A OliveriaSteven M Asch
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Ihab Hajjar, Theodore A Kotchen
Apr 16, 2005·American Journal of Hypertension·Karen L MargolisRichard H Grimm
May 9, 2007·The Journal of Clinical Hypertension·Thomas GilesFeride Frech-Tamas

❮ Previous
Next ❯

Citations

Oct 14, 2008·Expert Opinion on Biological Therapy·Shannon A MillerErin L St Onge
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·Claudio FariaDaniel A Belletti
Aug 27, 2010·Journal of Evaluation in Clinical Practice·Arden R BarryKaren G Lee
Feb 11, 2011·Health Services Research·Teryl K NuckolsElizabeth McGlynn
Oct 27, 2011·Pharmacotherapy·Karen J McConnellUNKNOWN Clinical Pharmacy Cardiac Risk Service Study Group
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Femida H Gwadry-SridharMaja Grubisic
Mar 15, 2011·Clinical Therapeutics·Jaco VoorhamUNKNOWN Groningen Initiative to Analyze Type 2 Diabetes Treatment Group
Oct 5, 2016·Journal of the American Society of Hypertension : JASH·William E HaleyUNKNOWN SPRINT Study Research Group
Apr 3, 2010·American Journal of Hypertension·Caroline H P A van de Steeg-van GompelPeter A G M De Smet
Jan 31, 2018·Current Hypertension Reports·Robina Josiah WillockPhillip D Levy
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Neesha N ChomaChristianne L Roumie
Sep 17, 2008·Expert Review of Cardiovascular Therapy·Vivencio BarriosFrancisco Medialdea
Oct 2, 2019·Frontiers in Aging Neuroscience·Jongjoo SunJ Mikhail Kellawan
Nov 25, 2017·The Journal of Clinical Hypertension·Ana C CabralIsabel V Figueiredo
Oct 26, 2018·Hypertension·Robert M CareyUNKNOWN American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council
May 4, 2018·International Journal of Hypertension·Nafees AhmadMuhammad Atif
Feb 21, 2019·Pharmacoepidemiology and Drug Safety·Si SiDanny Liew

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved